【醫藥護人員場】2. Prostate Cancer Screening、Observation、and Active Surveillance in Taiwan

00:00 1.
Prostate Cancer Screening、Observation and Active Surveillance in Taiwan
00:21 2.
Prostate Cancer in Taiwan攝護腺癌
00:54 3.
EAU Risk Groups for Prostate Cancer
02:06 4.
Natural History of Early Localized PC侷限性早期攝護腺癌之自然發展
02:49 5.
Natural History of Early Localized PC侷限性早期攝護腺癌之自然發展
03:24 6.
台灣攝護腺癌聯合資料庫 Cancer-Specific Survival by Stage
03:57 7.
治療早期前列腺癌常見之副作用
04:42 8.
Slide 8
04:52 9.
Comparison of Two Large Screening RCTS
05:33 10.
篩檢可以減少死亡率嗎 ?
05:58 11.
攝護腺癌早期檢測
06:58 12.
Slide 12
07:07 13.
Active Surveillance 積極監控
07:39 14.
Active Surveillance Versus Watchful Waiting
08:07 15.
Candidate for AS 積極監控
08:22 16.
Candidate for AS 積極監控
08:44 17.
Follow-up Protocol for AS
09:36 18.
Progression Criteria
10:08 19.
積極監控病患攝護腺切片常見之併發症
10:49 20.
積極監控之利弊
11:15 21.
積極監控之利弊
11:53 22.
Active Surveillance for Intermediate-Risk Prostate Cancer
12:33 23.
積極監控之長期預後
13:21 24.
Candidate for WW 觀察等待
14:03 25.
觀察等待之利弊
14:24 26.
攝護腺全切除 Versus 觀察等待
15:27 27.
ASCO Key Recommendations for AS and WW
16:25 28.
ASCO Key Recommendations for AS and WW
16:44 29.
台灣攝護腺癌聯合資料庫Treatments (Localized, T1-3N0M0)
17:23 30.
Take Home Message

未登入或權限不足!

講者：呂育全

日期：2016-05-10

觀看: 1767

00:00 1.
Prostate Cancer Screening、Observation and Active Surveillance in Taiwan
00:21 2.
Prostate Cancer in Taiwan攝護腺癌
00:54 3.
EAU Risk Groups for Prostate Cancer
02:06 4.
Natural History of Early Localized PC侷限性早期攝護腺癌之自然發展
02:49 5.
Natural History of Early Localized PC侷限性早期攝護腺癌之自然發展
03:24 6.
台灣攝護腺癌聯合資料庫 Cancer-Specific Survival by Stage
03:57 7.
治療早期前列腺癌常見之副作用
04:42 8.
Slide 8
04:52 9.
Comparison of Two Large Screening RCTS
05:33 10.
篩檢可以減少死亡率嗎 ?
05:58 11.
攝護腺癌早期檢測
06:58 12.
Slide 12
07:07 13.
Active Surveillance 積極監控
07:39 14.
Active Surveillance Versus Watchful Waiting
08:07 15.
Candidate for AS 積極監控
08:22 16.
Candidate for AS 積極監控
08:44 17.
Follow-up Protocol for AS
09:36 18.
Progression Criteria
10:08 19.
積極監控病患攝護腺切片常見之併發症
10:49 20.
積極監控之利弊
11:15 21.
積極監控之利弊
11:53 22.
Active Surveillance for Intermediate-Risk Prostate Cancer
12:33 23.
積極監控之長期預後
13:21 24.
Candidate for WW 觀察等待
14:03 25.
觀察等待之利弊
14:24 26.
攝護腺全切除 Versus 觀察等待
15:27 27.
ASCO Key Recommendations for AS and WW
16:25 28.
ASCO Key Recommendations for AS and WW
16:44 29.
台灣攝護腺癌聯合資料庫Treatments (Localized, T1-3N0M0)
17:23 30.
Take Home Message

【醫藥護人員場】2. Prostate Cancer Screening、Observation、and Active Surveillance in Taiwan

長度: 18:27, 瀏覽: 1768, 最近修訂: 2017-05-09

演講時間：8:50-9:10

講者：呂育全醫師

現任職位/稱：

臺大醫院雲林分院泌尿科主治醫師

臺大醫工所博士班

00:00 1.
Prostate Cancer Screening、Observation and Active Surveillance in Taiwan
00:21 2.
Prostate Cancer in Taiwan攝護腺癌
00:54 3.
EAU Risk Groups for Prostate Cancer
02:06 4.
Natural History of Early Localized PC侷限性早期攝護腺癌之自然發展
02:49 5.
Natural History of Early Localized PC侷限性早期攝護腺癌之自然發展
03:24 6.
台灣攝護腺癌聯合資料庫 Cancer-Specific Survival by Stage
03:57 7.
治療早期前列腺癌常見之副作用
04:42 8.
Slide 8
04:52 9.
Comparison of Two Large Screening RCTS
05:33 10.
篩檢可以減少死亡率嗎 ?
05:58 11.
攝護腺癌早期檢測
06:58 12.
Slide 12
07:07 13.
Active Surveillance 積極監控
07:39 14.
Active Surveillance Versus Watchful Waiting
08:07 15.
Candidate for AS 積極監控
08:22 16.
Candidate for AS 積極監控
08:44 17.
Follow-up Protocol for AS
09:36 18.
Progression Criteria
10:08 19.
積極監控病患攝護腺切片常見之併發症
10:49 20.
積極監控之利弊
11:15 21.
積極監控之利弊
11:53 22.
Active Surveillance for Intermediate-Risk Prostate Cancer
12:33 23.
積極監控之長期預後
13:21 24.
Candidate for WW 觀察等待
14:03 25.
觀察等待之利弊
14:24 26.
攝護腺全切除 Versus 觀察等待
15:27 27.
ASCO Key Recommendations for AS and WW
16:25 28.
ASCO Key Recommendations for AS and WW
16:44 29.
台灣攝護腺癌聯合資料庫Treatments (Localized, T1-3N0M0)
17:23 30.
Take Home Message

位置

資料夾名稱

2016臺大攝護祭-醫藥護人員場

發表人

系統管理者

單位

泌尿部

建立

2016-05-10 12:22:00

最近修訂

2017-05-09 10:00:36

長度

18:27